Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
It was reported that intra-operatively, the right ventricular (rv) lead implant was placed in the direction of the right ventricular apex, however, no capture was observed.The patient had a narrow right ventricular cavity, and several locations were attempted for placement and programming was done to optimize pacing for the patient.When the stylet was articulated for placement above septum, it was found out that the blood pressure could not be measured.When the cardiac shadow was checked with fluoroscopy, there was no heartbeat, a cardiac tamponade/blockage was determined, and drainage was performed.There was no noted resistance or stress felt during the placement attempt, and it was unknown where the cardiac tamponade/blockage occurred.Preparation was made for thoracotomy, but due to minimal bleeding, the patient was placed in the intensive care unit (icu) for observation.The lead was not used.No further patient complications have been reported as a result of this event.
|